Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
Ticker SymbolSNWV
Company nameSANUWAVE Health Inc
IPO dateNov 07, 2008
CEOFrank (Morgan C)
Number of employees46
Security typeOrdinary Share
Fiscal year-endNov 07
Address9600 W. 6Th Sstreet
CityEDEN PRAIRIE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55344
Phone19526561029
Websitehttps://sanuwave.com/
Ticker SymbolSNWV
IPO dateNov 07, 2008
CEOFrank (Morgan C)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data